Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
China
Biotech
Yarrow blooms with $1.37B autoimmune thyroid disease deal
Through a deal worth up to $1.37 billion, New York-based Yarrow gains ex-China rights to a potential first-in-class antibody targeting TSHR.
Angus Liu
Dec 16, 2025 11:00am
Formation Bio makes $605M play for Lynk's TYK2 inhibitor
Dec 10, 2025 10:27am
Pfizer Ventures gets behind Chinese biotech's $100M series A
Dec 5, 2025 4:20am
Fierce Pharma
WuXi AppTec faces new security scrutiny from Pentagon: Bloomberg
Dec 4, 2025 8:55am
Federal commission warns that US is losing innovative edge
Nov 25, 2025 3:47pm
Cornerstone secures $200M to take its surgical robot global
Nov 18, 2025 9:45am
